๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial

โœ Scribed by Hagop M Kantarjian; Andreas Hochhaus; Giuseppe Saglio; Carmino De Souza; Ian W Flinn; Leif Stenke; Yeow-Tee Goh; Gianantonio Rosti; Hirohisa Nakamae; Neil J Gallagher; Albert Hoenekopp; Rick E Blakesley; Richard A Larson; Timothy P Hughes


Book ID
117785742
Publisher
The Lancet
Year
2011
Tongue
English
Weight
319 KB
Volume
12
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES